Neogen Corporation Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Neogen Corporation stock issued during period, shares, employee stock purchase plans for the quarter ending 2022-02-28 was 24.00K shares, a 20.00% increase year-over-year.
- Neogen Corporation stock issued during period, shares, employee stock purchase plans for the quarter ending 2021-08-31 was 19.00K shares, a 5.56% increase year-over-year.
- Neogen Corporation stock issued during period, shares, employee stock purchase plans for the quarter ending 2021-02-28 was 20.00K shares.
- Neogen Corporation stock issued during period, shares, employee stock purchase plans for the quarter ending 2020-08-31 was 18.00K shares.
- Neogen Corporation stock issued during period, shares, employee stock purchase plans for fiscal 2026 was 300.00K shares, a 50.00% increase from fiscal 2025.
- Neogen Corporation stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 200.00K shares, a 100.00% increase from fiscal 2024.
- Neogen Corporation stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 100.00K shares, a 5.70% increase from fiscal 2023.
- Neogen Corporation stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 94.60K shares, a 117.70% increase from fiscal 2022.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2026-05-31 | 300.00K shares 10-K · filed 2026-07-30 | |
| 2025-05-31 | 200.00K shares 10-K · filed 2026-07-30 | |
| 2024-05-31 | 100.00K shares 10-K · filed 2026-07-30 | |
| 2023-05-31 | 94.60K shares 10-K · filed 2025-07-30 | |
| 2022-05-31 | 43.46K shares 10-K · filed 2024-07-30 | |
| 2022-02-28 | 24.00K shares 10-Q · filed 2022-04-01 | |
| 2021-08-31 | 19.00K shares 10-Q · filed 2022-04-01 | |
| 2021-05-31 | 38.41K shares 10-K · filed 2023-08-15 | |
| 2021-02-28 | 20.00K shares 10-Q · filed 2022-04-01 | |
| 2020-08-31 | 18.00K shares 10-Q · filed 2022-04-01 | |
| 2020-05-31 | 43.16K shares 10-K · filed 2022-07-27 | |
| 2019-05-31 | 36.66K shares 10-K · filed 2021-07-30 | |
| 2018-05-31 | 22.13K shares 10-K · filed 2020-07-30 | |
| 2017-05-31 | 24.95K shares 10-K · filed 2019-07-30 | |
| 2016-05-31 | 24.37K shares 10-K · filed 2018-07-27 | |
| 2015-05-31 | 19.59K shares 10-K · filed 2017-07-28 | |
| 2014-05-31 | 18.47K shares 10-K · filed 2016-07-29 | |
| 2013-05-31 | 22.39K shares 10-K · filed 2015-07-30 | |
| 2012-05-31 | 21.22K shares 10-K · filed 2014-07-30 | |
| 2011-05-31 | 18.25K shares 10-K · filed 2013-07-30 | |
| 2010-05-31 | 19.83K shares 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |